The best indicator for BlackRock (BLK)
We backtested 20 indicators across daily, weekly and hourly charts on real BlackRock (BLK) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
RSI Trend (>50)
On the weekly chart, this is the strongest risk-adjusted edge we found for BlackRock (BLK) over ~26.8 years — trailing buy-and-hold by 6.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | RSI Trend (>50) ✓ | Weekly | 13.3% | 0.64 | -45.6% | 43.5% | 69 | -6.2% |
| 2 | EMA 20/50 Cross ✓ | Daily | 12.4% | 0.61 | -39.9% | 45.8% | 59 | -7.2% |
| 3 | Donchian Breakout ✓ | Weekly | 11.5% | 0.61 | -34.1% | 70.0% | 20 | -8.0% |
| 4 | Rate of Change ✓ | Weekly | 11.6% | 0.59 | -59.8% | 56.0% | 91 | -7.9% |
| 5 | Donchian Midline ✓ | Weekly | 11.2% | 0.57 | -48.7% | 43.9% | 66 | -8.3% |
| 6 | MACD ✓ | Weekly | 9.3% | 0.54 | -46.9% | 53.7% | 54 | -10.3% |
| 7 | ADX / DMI ✓ | Daily | 8.2% | 0.51 | -28.6% | 43.0% | 158 | -11.5% |
| 8 | ADX / DMI | Weekly | 9.1% | 0.51 | -45.3% | 53.7% | 41 | -10.4% |
| 9 | EMA-10 Trend ✓ | Weekly | 8.6% | 0.48 | -45.5% | 49.6% | 125 | -10.9% |
| 10 | Stochastic | Daily | 7.2% | 0.44 | -46.1% | 66.2% | 133 | -12.4% |
| 11 | SMA 50/200 Cross ✓ | Daily | 7.7% | 0.42 | -54.8% | 50.0% | 22 | -12.0% |
| 12 | Holy Grail Confluence ✓ | Daily | 6.8% | 0.42 | -40.5% | 76.9% | 39 | -12.9% |
| 13 | Bollinger Breakout ✓ | Weekly | 6.0% | 0.42 | -31.4% | 53.8% | 26 | -13.5% |
| 14 | Stochastic ✓ | Weekly | 6.1% | 0.41 | -36.7% | 79.2% | 24 | -13.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For BlackRock (BLK), RSI Trend (>50) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.